I get why you’d feel that way — the past doesn’t exactly inspire confidence. But in my view: cash at Dec 31 was $8.46m before the $1.05m R&D refund in Jan. Based on my rough estimate, trial costs should drop by ~$1m/quarter from May once recruitment concludes. So while another raise wouldn’t surprise me, I’m not convinced we’re locked into “multiple cap raises every year” territory anymore (thank god). And with the March quarterly due in under 10 days, we’ll have a better sense of how things are tracking pretty soon.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.01 |
Change
-0.025(2.43%) |
Mkt cap ! $14.29M | |||
| Open | High | Low | Value | Volume |
| $1.04 | $1.05 | $1.00 | $41.05K | 40.86K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $1.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.05 | 1249 | 1 |
View Market Depth
| Last trade - 15.47pm 20/06/2025 (20 minute delay) ? |
| OSL (ASX) Chart |